3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Triple Negative Breast Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasm Metastasis
2
Melanoma
2
Lung Neoplasms
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Myeloid, Acute
2
Carcinoma, Renal Cell
2
Urinary Bladder Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Pinealoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Ovarian Diseases
1
Neuroendocrine Tumors
1
Myeloproliferative Disorders
1
Mammary Neoplasms, Animal
1
Lymphoma
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Kidney Neoplasms
1
Hodgkin Disease
1
Fallopian Tube Neoplasms
1
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
1
Interventions
Temozolomide
29
Bevacizumab
15
Radiotherapy
13
antineoplaston AS 2-1
8
antineoplaston A10
8
Everolimus
7
Radiation
6
Erlotinib Hydrochloride
6
Radiotherapy, Intensity-Modulated
5
Lomustine
4
veliparib
3
palbociclib
3
Vorinostat
3
Sunitinib
3
Radiotherapy, Conformal
3
Magnetic Resonance Spectroscopy
3
Carmustine
3
Carboplatin
3
temsirolimus
2
selinexor
2
poly ICLC
2
etoposide phosphate
2
cabozantinib
2
Sirolimus
2
Nivolumab
2
Irinotecan
2
Immunoglobulin G
2
Imatinib Mesylate
2
Etoposide
2
Donepezil
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Astrocytoma
×
entinostat
×
Clear all
No trials found.